Prognostic indicators for response to therapy and survival in patients with metastatic renal cell cancer treated with interferon alpha-2 beta and vinblastine (Q51010247)
scientific article published in September 1996
Language:
Current Data About Prognostic indicators for response to therapy and survival in patients with metastatic renal cell cancer treated with interferon alpha-2 beta and vinblastine
(P31) (Q13442814)
(P248)
(P698) 8804488
(P813) Tuesday, March 27, 2018
(P854) http://europepmc.org/abstract/MED/8804488

(P304) 373-378
(P248)
(P698) 8804488
(P813) Tuesday, March 27, 2018
(P854) http://europepmc.org/abstract/MED/8804488

(P407) (Q1860)

(P433) 3
(P248)
(P698) 8804488
(P813) Tuesday, March 27, 2018
(P854) http://europepmc.org/abstract/MED/8804488

(P478) 48
(P248)
(P698) 8804488
(P813) Tuesday, March 27, 2018
(P854) http://europepmc.org/abstract/MED/8804488

(P577) Sunday, September 1, 1996
(P248)
(P698) 8804488
(P813) Tuesday, March 27, 2018
(P854) http://europepmc.org/abstract/MED/8804488

(P1433) (Q7900884)
(P248)
(P698) 8804488
(P813) Tuesday, March 27, 2018
(P854) http://europepmc.org/abstract/MED/8804488

(P1476) "Prognostic indicators for response to therapy and survival in patients with metastatic renal cell cancer treated with interferon alpha-2 beta and vinblastine" (language: en)
(P248)
(P698) 8804488
(P813) Tuesday, March 27, 2018
(P854) http://europepmc.org/abstract/MED/8804488

(P2093) I Papadopoulos
(P1545) 1
(P248)
(P698) 8804488
(P813) Tuesday, March 27, 2018
(P854) http://europepmc.org/abstract/MED/8804488

P Rudolph
(P1545) 2
(P248)
(P698) 8804488
(P813) Tuesday, March 27, 2018
(P854) http://europepmc.org/abstract/MED/8804488

K Weichert-Jacobsen
(P1545) 3
(P248)
(P698) 8804488
(P813) Tuesday, March 27, 2018
(P854) http://europepmc.org/abstract/MED/8804488

O Thiemann
(P1545) 4
(P248)
(P698) 8804488
(P813) Tuesday, March 27, 2018
(P854) http://europepmc.org/abstract/MED/8804488

D Papadopoulou
(P1545) 5
(P248)
(P698) 8804488
(P813) Tuesday, March 27, 2018
(P854) http://europepmc.org/abstract/MED/8804488

(P2860) (Q68709987)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9
(P813) Thursday, January 7, 2021
(P887)

(Q67998158)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9
(P813) Thursday, January 7, 2021
(P887)

(Q68709984)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9
(P813) Thursday, January 7, 2021
(P887)

(Q53475970)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9
(P813) Thursday, January 7, 2021
(P887)

(Q72667215)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9
(P813) Thursday, January 7, 2021
(P887)

(Q69578343)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9
(P813) Thursday, January 7, 2021
(P887)

(Q33263235)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9
(P813) Thursday, January 7, 2021
(P887)

(Q43452639)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9
(P813) Thursday, January 7, 2021
(P887)

(Q55488640)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9
(P813) Thursday, January 7, 2021
(P887)

(Q72655187)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9
(P813) Thursday, January 7, 2021
(P887)

(Q44781230)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9
(P813) Thursday, January 7, 2021
(P887)

(Q70408086)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9
(P813) Thursday, January 7, 2021
(P887)

(Q41827234)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9
(P813) Thursday, January 7, 2021
(P887)

(Q33374365)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900168-9
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article published in September 1996

External Links
(P356) 10.1016/S0090-4295(96)00168-9
(P698) 8804488